Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000222,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67475,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000213,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67476,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000316,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67477,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000339,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67478,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000046,blood glucose level,,,,78,mg/dl,2.6,6.879,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12770,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000046,blood glucose level,,,,78.7,mg/dl,3.4,8.9956,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12786,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000046,blood glucose level,,,,82.5,mg/dl,3.5,11.6082,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12792,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000046,blood glucose level,,,,87.7,mg/dl,3.2,10.6132,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12798,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) ", 312,"Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9.",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,149.2,mg/dl,3.0,11.225,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,fasting (for 16 hours) then glucose solution,12776,fasting (for 16 hours),glucose solution,, 312,"Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9.",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,344.3,mg/dl,8.5,31.8041,MMO:0000113,oral glucose tolerance test,,0.0,,glucose challenge,30,min,fasting (for 16 hours) then glucose solution (for 0.5 hours),12777,fasting (for 16 hours),glucose solution (for 0.5 hours),, 312,"Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9.",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,91.3,mg/dl,1.5,6.7082,MMO:0000113,oral glucose tolerance test,,0.0,,glucose challenge,0,min,fasting (for 16 hours) then glucose solution,12779,fasting (for 16 hours),glucose solution,, 312,"Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9.",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,124.8,mg/dl,2.3,10.2859,MMO:0000113,oral glucose tolerance test,,0.0,,glucose challenge,30,min,fasting (for 16 hours) then glucose solution (for 0.5 hours),12783,fasting (for 16 hours),glucose solution (for 0.5 hours),, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000625,OLETF/Got,male,245 days,14,,CMO:0000042,plasma glucose level,,converted from mg/dl,,102.2,mg/dl,2.7528,10.3,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,0,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11402,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000625,OLETF/Got,male,245 days,14,,CMO:0000042,plasma glucose level,,converted from mg/dl,,301.3,mg/dl,8.2316,30.8,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,30,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11403,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,245 days,15,,CMO:0000042,plasma glucose level,,converted from mg/dl,,92.6,mg/dl,1.6525,6.4,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,30,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11405,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",, 83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,245 days,15,,CMO:0000042,plasma glucose level,,converted from mg/dl,,80,mg/dl,1.2394,4.8,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,0,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11404,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000228,mg/dl,0.0,0.0,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12900,controlled protein content diet (for 120 days),fasting (for 9 hours),, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000452,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12904,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000191,mg/dl,0.0,0.0,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12911,controlled protein content diet (for 120 days),fasting (for 9 hours),, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000195,mg/dl,1.0E-4,1.0E-4,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12912,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,140.2,mg/dl,13.4,29.9633,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12887,controlled protein content diet (for 120 days),fasting (for 9 hours),, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,266.7,mg/dl,13.9,31.0813,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12892,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,313.5,mg/dl,25.9,57.9142,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,60,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12895,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,216.9,mg/dl,8.6,19.2302,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,120,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12896,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,145.1,mg/dl,16.4,36.6715,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12907,controlled protein content diet (for 120 days),fasting (for 9 hours),, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,178.1,mg/dl,7.9,17.6649,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12908,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,211.3,mg/dl,17.9,40.0256,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,60,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12909,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood glucose amount,WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000046,blood glucose level,,serum glucose,,154.7,mg/dl,13.8,30.8577,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,120,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12910,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution, 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,99,mg/dl,4.48,11.853,MMO:0000113,oral glucose tolerance test,,0,,oral dose,0,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13156,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,134.1,mg/dl,4.7,12.435,MMO:0000113,oral glucose tolerance test,,0,,oral dose,15,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13157,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149.1,mg/dl,4.2,11.1122,MMO:0000113,oral glucose tolerance test,,0,,oral dose,30,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13158,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,157,mg/dl,5.21,13.7844,MMO:0000113,oral glucose tolerance test,,0,,oral dose,60,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13159,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149,mg/dl,3.52,9.313,MMO:0000113,oral glucose tolerance test,,0,,oral dose,120,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13160,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000046,blood glucose level,,,,566.2,mg/dl,26.69,59.6807,MMO:0000113,oral glucose tolerance test,,0,,oral dose,0,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13162,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000046,blood glucose level,,,,705,mg/dl,46.77,104.5809,MMO:0000113,oral glucose tolerance test,,0,,oral dose,15,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13164,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000046,blood glucose level,,,,767.2,mg/dl,17.6,39.3548,MMO:0000113,oral glucose tolerance test,,0,,oral dose,30,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13166,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000046,blood glucose level,,,,702.8,mg/dl,25.39,56.7738,MMO:0000113,oral glucose tolerance test,,0,,oral dose,60,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13167,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000046,blood glucose level,,,,640.6,mg/dl,16.99,37.9908,MMO:0000113,oral glucose tolerance test,,0,,oral dose,120,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13168,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000709,SDT/Jcl,male,420 days,5,,CMO:0000350,blood glucose level area under curve (AUC),,,,8.3,(mg/dl) x min,1.91,4.2709,MMO:0000113,oral glucose tolerance test,,0.0,trapezoid rule used for calculation,oral dose,,,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,11604,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,1.8,(mg/dl) x min,0.52,1.3758,MMO:0000113,oral glucose tolerance test,,0,trapezoid rule used for calculation,oral dose,,,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,11606,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) , 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,153,mg/dl,3.4,10.7517,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13196,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,332.1,mg/dl,8.0,25.2982,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13197,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,337.9,mg/dl,7.9,24.982,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13198,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,423.5,mg/dl,23.6,74.6298,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13199,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,289.7,mg/dl,8.2,25.9307,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13200,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,104,mg/dl,6.1,16.1391,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13201,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,124.1,mg/dl,1.6,4.2332,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13202,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,130.9,mg/dl,2.9,7.6727,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13203,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,139,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13204,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,128,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13205,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,15300,(mg/dl) x min,206.7,546.8768,MMO:0000113,oral glucose tolerance test,tail,0.0,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67194,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,39445.5,(mg/dl) x min,1058.0,3345.6898,MMO:0000113,oral glucose tolerance test,tail,0.0,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67195,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,87,mg/dl,1.2,5.6285,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13206,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,1.5,7.0356,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13207,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,112,mg/dl,2.2,10.3189,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13208,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,106,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13209,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,107.3,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13210,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,88.8,mg/dl,1.4,5.6,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13211,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,127,mg/dl,3.2,12.8,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13212,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,127.1,mg/dl,3.5,14.0,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13213,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,126.8,mg/dl,2.7,10.8,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13214,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,124.8,mg/dl,2.6,10.4,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13215,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,85.9,mg/dl,1.8,6.9714,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13216,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,114.6,mg/dl,3.2,12.3935,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13217,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,116.4,mg/dl,2.9,11.2317,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13218,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,114.8,mg/dl,3.0,11.619,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13219,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,111.9,mg/dl,2.5,9.6825,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13220,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,89.5,mg/dl,1.1,4.7948,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13221,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,120.7,mg/dl,2.5,10.8972,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13222,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,125.4,mg/dl,3.2,13.9485,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13223,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,118.8,mg/dl,2.4,10.4614,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13224,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,119.3,mg/dl,3.1,13.5126,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13225,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,89.8,mg/dl,2.2,7.9322,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13226,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,118.5,mg/dl,3.5,12.6194,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13227,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,119.5,mg/dl,2.1,7.5717,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13228,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,119.8,mg/dl,3.4,12.2589,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13229,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,122.6,mg/dl,3.1,11.1772,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13230,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,89.5,mg/dl,2.2,8.5206,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13231,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,108.2,mg/dl,2.9,11.2317,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13232,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,110.4,mg/dl,2.8,10.8444,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13233,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,107.4,mg/dl,2.3,8.9079,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13234,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,105.9,mg/dl,2.0,7.746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13235,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,80,mg/dl,2.9,10.0459,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13236,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.8,mg/dl,2.6,9.0067,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13237,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,113,mg/dl,2.6,9.0067,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13238,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.6,mg/dl,2.1,7.2746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13239,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.5,mg/dl,2.1,7.2746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13240,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,90,mg/dl,4.2,13.2816,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13241,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,118.4,mg/dl,4.0,12.6491,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13242,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.3,mg/dl,2.2,6.957,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13243,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.2,mg/dl,2.7,8.5381,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13244,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.2,mg/dl,3.4,10.7517,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13245,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,81.3,mg/dl,2.0,5.6569,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13246,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,100.1,mg/dl,2.4,6.7882,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13247,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,99.6,mg/dl,3.2,9.051,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13248,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,101.1,mg/dl,3.4,9.6167,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13249,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,103.5,mg/dl,3.0,8.4853,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13250,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,84.4,mg/dl,1.5,5.4083,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13251,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,100,mg/dl,2.3,8.2928,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13252,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,103,mg/dl,2.6,9.3744,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13253,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,102.2,mg/dl,1.8,6.49,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13254,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,103.5,mg/dl,2.3,8.2928,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13255,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,91.4,mg/dl,1.1,4.1158,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13256,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,114.8,mg/dl,1.9,7.1091,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13257,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,118.3,mg/dl,1.7,6.3608,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13258,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,119,mg/dl,2.0,7.4833,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13259,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,118.9,mg/dl,2.2,8.2316,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13260,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,89,mg/dl,2.4,7.5895,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13261,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,105.9,mg/dl,2.6,8.2219,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13262,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,105.8,mg/dl,2.8,8.8544,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13263,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,102.2,mg/dl,2.4,7.5895,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13264,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,102,mg/dl,2.6,8.2219,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13265,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,84.7,mg/dl,1.9,5.0269,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13266,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,100.9,mg/dl,3.0,7.9373,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13267,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13268,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,96.7,mg/dl,1.2,3.1749,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13269,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,103.7,mg/dl,1.2,3.1749,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13270,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000350,blood glucose level area under curve (AUC),,,,12619.8,(mg/dl) x min,142.8,669.7914,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67778,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000350,blood glucose level area under curve (AUC),,,,14626.9,(mg/dl) x min,209.1,836.4,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67779,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000350,blood glucose level area under curve (AUC),,,,13342,(mg/dl) x min,278.7,1079.4005,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67780,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000350,blood glucose level area under curve (AUC),,,,14077.1,(mg/dl) x min,223.3,973.3421,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67781,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000350,blood glucose level area under curve (AUC),,,,13921.2,(mg/dl) x min,193.4,697.3136,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67782,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000350,blood glucose level area under curve (AUC),,,,12711.3,(mg/dl) x min,281.0,1088.3083,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67783,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000350,blood glucose level area under curve (AUC),,,,13082.5,(mg/dl) x min,171.3,593.4006,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67784,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,13545,(mg/dl) x min,178.8,565.4152,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67785,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000350,blood glucose level area under curve (AUC),,,,11797.5,(mg/dl) x min,291.2,823.638,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67786,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000350,blood glucose level area under curve (AUC),,,,11972.3,(mg/dl) x min,199.4,718.9469,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67787,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000350,blood glucose level area under curve (AUC),,,,13716.4,(mg/dl) x min,166.7,623.7343,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67788,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,12282,(mg/dl) x min,221.8,701.3932,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67789,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,11920.7,(mg/dl) x min,192.1,508.2488,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67790,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000358,serum insulin level,,,,0.000301,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66176,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000358,serum insulin level,,,,0.000408,mg/dl,0.0,2.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66177,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000042,plasma glucose level,,,,80,mg/dl,3.1,9.3,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66172,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000042,plasma glucose level,,,,88.1,mg/dl,1.8,8.0498,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66173,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000350,blood glucose level area under curve (AUC),,,,12200,(mg/dl) x min,174.0,522.0,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66174,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000350,blood glucose level area under curve (AUC),,,,14600,(mg/dl) x min,354.0,1583.1361,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66175,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",, 729,"Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6.",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,289,mg/dl,8.5524,32.0,MMO:0000113,oral glucose tolerance test,,0.0,,oral dose,120,min,fasting (for 16 hours) then glucose solution,67277,fasting (for 16 hours),glucose solution,, 729,"Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6.",blood glucose amount,,RS:0001349,LETO,male,210 days,14,,CMO:0000042,plasma glucose level,,,,150,mg/dl,1.8708,7.0,MMO:0000113,oral glucose tolerance test,,0.0,,oral dose,120,min,fasting (for 16 hours) then glucose solution,67278,fasting (for 16 hours),glucose solution,, 729,"Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6.",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,128,mg/dl,2.2678,6.0,MMO:0000113,oral glucose tolerance test,,0.0,,oral dose,120,min,fasting (for 16 hours) then glucose solution,67279,fasting (for 16 hours),glucose solution,, 833,"Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206.",blood glucose amount,,RS:0000430,BN/Seac,male,140 days,N/A,,CMO:0000350,blood glucose level area under curve (AUC),,,,17646,(mg/dl) x min,510.0,,MMO:0000113,oral glucose tolerance test,,0.0,,oral dose,120,min,fasting (for 18 hours) then glucose solution (2 g/kg) ,67911,fasting (for 18 hours),glucose solution (2 g/kg) ,, 833,"Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206.",blood glucose amount,,RS:0000709,SDT/Jcl,male,140 days,N/A,,CMO:0000350,blood glucose level area under curve (AUC),,,,37998,(mg/dl) x min,1584.0,,MMO:0000113,oral glucose tolerance test,,0.0,,oral dose,120,min,fasting (for 18 hours) then glucose solution (2 g/kg) ,67912,fasting (for 18 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,91.3,mg/dl,1.5,6.7082,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68069,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000042,plasma glucose level,,,,104,mg/dl,6.1,16.1391,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68070,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,149.2,mg/dl,3.0,11.225,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68071,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,124.8,mg/dl,2.3,10.2859,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68072,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000042,plasma glucose level,,,,124.1,mg/dl,1.6,4.2332,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68073,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,344.3,mg/dl,8.5,31.8041,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68074,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,129.8,mg/dl,1.7,7.6026,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68075,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000042,plasma glucose level,,,,185.5,mg/dl,4.0,10.583,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68076,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,352.8,mg/dl,8.6,32.1783,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68077,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,138.7,mg/dl,2.6,11.6276,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68078,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000042,plasma glucose level,,,,139,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68079,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,402.4,mg/dl,19.0,71.0915,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68080,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000113,BN,male,210 days,20,,CMO:0000042,plasma glucose level,,,,120.5,mg/dl,2.6,11.6276,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68081,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000313,F344/NRrrc,male,210 days,7,,CMO:0000042,plasma glucose level,,,,128,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68082,fasting (for 16 hours),glucose solution (2 g/kg) ,, 836,"Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25",blood glucose amount,,RS:0000284,OLETF,male,210 days,14,,CMO:0000042,plasma glucose level,,,,289.9,mg/dl,8.7,32.5524,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,68083,fasting (for 16 hours),glucose solution (2 g/kg) ,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000543,serum glucose level,,,,94.38,mg/dl,2.9639,7.26,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,fasting (for 16 hours),70236,fasting (for 16 hours),,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000543,serum glucose level,,,,78.045,mg/dl,1.4819,3.63,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,fasting (for 16 hours),70237,fasting (for 16 hours),,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000543,serum glucose level,,,,88.935,mg/dl,1.4819,3.63,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70238,controlled sucrose content diet (for 7 days),fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000543,serum glucose level,,,,74.415,mg/dl,3.7049,9.075,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70239,controlled sucrose content diet (for 7 days),fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,375.705,mg/dl,12.5965,30.855,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70240,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000543,serum glucose level,,,,252.285,mg/dl,28.1569,68.97,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,0,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70241,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15152.7271212,(mg/dl) x min,298.3924,730.9091,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,fasting (for 16 hours),70268,fasting (for 16 hours),,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,14454.54531,(mg/dl) x min,247.1758,605.4545,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,fasting (for 16 hours),70269,fasting (for 16 hours),,, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15169.0907574,(mg/dl) x min,239.0108,585.4545,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70270,controlled sucrose content diet (for 7 days),fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,15850.9089324,(mg/dl) x min,1065.1569,2609.0909,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70271,controlled sucrose content diet (for 7 days),fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,57081.817611,(mg/dl) x min,512.9083,1256.3636,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70272,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood glucose amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000350,blood glucose level area under curve (AUC),,,,42156.3632148,(mg/dl) x min,1723.55,4221.8181,MMO:0000113,oral glucose tolerance test,tail vein,0.0,,intragastric glucose,120,min,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70273,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000046,blood glucose level,,,,162,mg/dl,14.0,28.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103808,sodium chloride solution (for 23 days),control condition (for 20 days),fasting (for 16 hours),glucose solution (2 g/kg) 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,77 days to 70 days,6,,CMO:0000046,blood glucose level,,,,209,mg/dl,4.899,12.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose solution (2 g/kg) ,103804,fasting (for 16 hours),glucose solution (2 g/kg) ,, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0000046,blood glucose level,,,,168,mg/dl,9.0,18.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,sodium chloride solution (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103805,sodium chloride solution (for 23 days),fasting (for 16 hours),glucose solution (2 g/kg) , 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,3,,CMO:0000046,blood glucose level,,,,146,mg/dl,3.4641,6.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103806,rosiglitazone (5 mg/kg) (for 23 days),fasting (for 16 hours),glucose solution (2 g/kg) , 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0000046,blood glucose level,,,,142,mg/dl,4.0,8.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103807,rosiglitazone (10 mg/kg) (for 23 days),fasting (for 16 hours),glucose solution (2 g/kg) , 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000046,blood glucose level,,,,145,mg/dl,7.5,15.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103810,rosiglitazone (10 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 16 hours),glucose solution (2 g/kg) 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood glucose amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000046,blood glucose level,,,,177,mg/dl,5.5,11.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) ,103809,rosiglitazone (5 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 16 hours),glucose solution (2 g/kg) 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,77 days to 70 days,6,,CMO:0000342,plasma insulin level,,,,37.18,mU/l,3.9273,9.62,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 12 hours),103811,fasting (for 12 hours),,, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0000342,plasma insulin level,,,,38.74,mU/l,7.28,14.56,MMO:0000113,oral glucose tolerance test,,0.0,,,,,sodium chloride solution (for 23 days) then fasting (for 12 hours),103812,sodium chloride solution (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,3,,CMO:0000342,plasma insulin level,,,,30.42,mU/l,4.2031,7.28,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours),103813,rosiglitazone (5 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0000342,plasma insulin level,,,,34.58,mU/l,4.68,9.36,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours),103814,rosiglitazone (10 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000342,plasma insulin level,,,,37.96,mU/l,6.5,13.0,MMO:0000113,oral glucose tolerance test,,0.0,,,,,sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103815,sodium chloride solution (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000342,plasma insulin level,,,,38.22,mU/l,5.2,10.4,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103816,rosiglitazone (5 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0000342,plasma insulin level,,,,27.3,mU/l,4.16,8.32,MMO:0000113,oral glucose tolerance test,,0.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103817,rosiglitazone (10 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,77 days to 70 days,6,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,16.2,,1.633,4.0,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,fasting (for 12 hours),103832,fasting (for 12 hours),,, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,13.6,,2.85,5.7,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,sodium chloride solution (for 23 days) then fasting (for 12 hours),103833,sodium chloride solution (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,3,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,9.8,,1.2124,2.1,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours),103834,rosiglitazone (5 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,10.2,,1.35,2.7,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours),103835,rosiglitazone (10 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,13,,2.65,5.3,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103836,sodium chloride solution (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,14.2,,2.15,4.3,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103837,rosiglitazone (5 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003002,Homeostatic Model Assessment of Insulin Resistance,(fasting glucose x fasting insulin)/22.5,,,8.2,,1.35,2.7,MMO:0000113,oral glucose tolerance test,,7200.0,,,,,rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103838,rosiglitazone (10 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,77 days to 70 days,6,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000393,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,120.0,"measured at -5,15,30,45,60,90,120 min",,,,fasting (for 12 hours),103818,fasting (for 12 hours),,, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000503,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,sodium chloride solution (for 23 days) then fasting (for 12 hours),103819,sodium chloride solution (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,3,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000398,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours),103820,rosiglitazone (5 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.00005,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours),103821,rosiglitazone (10 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000428,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103822,sodium chloride solution (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000485,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103823,rosiglitazone (5 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003000,blood insulin level AUC to blood glucose level AUC ratio,AUC ins/glu,,,0.0000398,,0.0,0.0,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103824,rosiglitazone (10 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,77 days to 70 days,6,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.94,,0.098,0.24,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,fasting (for 12 hours),103825,fasting (for 12 hours),,, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.37,,0.245,0.49,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,sodium chloride solution (for 23 days) then fasting (for 12 hours),103826,sodium chloride solution (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,3,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.73,,0.1963,0.34,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours),103827,rosiglitazone (5 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,102 days to 95 days,4,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.72,,0.295,0.59,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours),103828,rosiglitazone (10 mg/kg) (for 23 days),fasting (for 12 hours),, 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.49,,0.31,0.62,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103829,sodium chloride solution (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,1.27,,0.23,0.46,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103830,rosiglitazone (5 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2864,"Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.",blood insulin amount,,RS:0001317,GK/MolTac,male,129 days to 122 days,4,,CMO:0003001,whole body insulin sensitivity index,"10,000/√(FG x FI) x (Ḡ x Ī)",,,2.04,,0.21,0.42,MMO:0000113,oral glucose tolerance test,,7200.0,"measured at -5,15,30,45,60,90,120 min",,,,rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours),103831,rosiglitazone (10 mg/kg) (for 23 days),control condition (for 20 days),fasting (for 12 hours), 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0000731,WKY/NCrl,male,134 days,6,,CMO:0000046,blood glucose level,,,,124,mg/dl,3.0,7.3485,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103514,fasting (for 16 hours),glucose (2 g/kg) (for 2 hours),, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0000731,WKY/NCrl,male,134 days,6,,CMO:0000046,blood glucose level,,,,118,mg/dl,4.0,9.798,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103515,fasting (for 16 hours),glucose (2 g/kg) (for 2 hours),, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0001299,GK,male,134 days,6,,CMO:0000046,blood glucose level,,,,301,mg/dl,23.0,56.3383,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103516,fasting (for 16 hours),glucose (2 g/kg) (for 2 hours),, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0001299,GK,male,134 days,6,,CMO:0000046,blood glucose level,,,,331,mg/dl,30.0,73.4847,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103517,fasting (for 16 hours),glucose (2 g/kg) (for 2 hours),, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000046,blood glucose level,,,,125,mg/dl,3.0,7.3485,MMO:0000113,oral glucose tolerance test,,0.0,,,,,vehicle control condition (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103518,vehicle control condition (for 28 days),fasting (for 16 hours),glucose (2 g/kg) (for 2 hours), 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000046,blood glucose level,,,,121,mg/dl,2.0,4.899,MMO:0000113,oral glucose tolerance test,,0.0,,,,,salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103519,salidroside (40 mg/kg) (for 28 days),fasting (for 16 hours),glucose (2 g/kg) (for 2 hours), 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0001299,GK,male,168 days,6,,CMO:0000046,blood glucose level,,,,278,mg/dl,20.0,48.9898,MMO:0000113,oral glucose tolerance test,,0.0,,,,,vehicle control condition (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103520,vehicle control condition (for 28 days),fasting (for 16 hours),glucose (2 g/kg) (for 2 hours), 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",blood glucose amount,,RS:0001299,GK,male,168 days,6,,CMO:0000046,blood glucose level,,,,297,mg/dl,25.0,61.2372,MMO:0000113,oral glucose tolerance test,,0.0,,,,,salidroside (40 mg/kg) (for 28 days) then fasting (for 16 hours) then glucose (2 g/kg) (for 2 hours),103521,salidroside (40 mg/kg) (for 28 days),fasting (for 16 hours),glucose (2 g/kg) (for 2 hours), 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood glucose amount,,RS:0001299,GK,male,77 days,10,,CMO:0000042,plasma glucose level,,,,6.83,mg/dl,0.1297,0.41,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (between 0.5 and 3 hours),109089,fasting (for 16 hours),glucose (2 g/kg) (between 0.5 and 3 hours),, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood glucose amount,,RS:0001299,GK,male,77 days,10,,CMO:0000042,plasma glucose level,,,,6.84,mg/dl,0.1328,0.42,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (between 0.5 and 3 hours),109090,fasting (for 16 hours),glucose (2 g/kg) (between 0.5 and 3 hours),, 3111,"Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.",blood glucose amount,,RS:0001299,GK,male,77 days,10,,CMO:0000042,plasma glucose level,,,,6.74,mg/dl,0.2656,0.84,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (between 0.5 and 3 hours),109091,fasting (for 16 hours),glucose (2 g/kg) (between 0.5 and 3 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000046,blood glucose level,,,,124.2,mg/dl,7.2,22.7684,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (between 14 and 18 hours) then glucose,110745,fasting (between 14 and 18 hours),glucose,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000046,blood glucose level,,,,113.4,mg/dl,5.4,16.2,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (between 14 and 18 hours) then glucose,110746,fasting (between 14 and 18 hours),glucose,, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000046,blood glucose level,,,,250.2,mg/dl,21.6,61.094,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (between 14 and 18 hours) then glucose (for 0.5 hours),110747,fasting (between 14 and 18 hours),glucose (for 0.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000046,blood glucose level,,,,289.8,mg/dl,21.6,68.3052,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (between 14 and 18 hours) then glucose (for 0.5 hours),110748,fasting (between 14 and 18 hours),glucose (for 0.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000046,blood glucose level,,,,289.8,mg/dl,12.6,37.8,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,30,min,fasting (between 14 and 18 hours) then glucose (for 0.5 hours),110749,fasting (between 14 and 18 hours),glucose (for 0.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000046,blood glucose level,,,,262.8,mg/dl,23.4,66.1852,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (between 14 and 18 hours) then glucose (for 1 hours),110750,fasting (between 14 and 18 hours),glucose (for 1 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000046,blood glucose level,,,,307.8,mg/dl,19.8,62.6131,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (between 14 and 18 hours) then glucose (for 1 hours),110751,fasting (between 14 and 18 hours),glucose (for 1 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000046,blood glucose level,,,,273.6,mg/dl,14.4,43.2,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,fasting (between 14 and 18 hours) then glucose (for 1 hours),110752,fasting (between 14 and 18 hours),glucose (for 1 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000046,blood glucose level,,,,253.8,mg/dl,16.2,45.8205,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (between 14 and 18 hours) then glucose (for 1.5 hours),110753,fasting (between 14 and 18 hours),glucose (for 1.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000046,blood glucose level,,,,279,mg/dl,14.4,45.5368,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (between 14 and 18 hours) then glucose (for 1.5 hours),110754,fasting (between 14 and 18 hours),glucose (for 1.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000046,blood glucose level,,,,244.8,mg/dl,12.6,37.8,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,90,min,fasting (between 14 and 18 hours) then glucose (for 1.5 hours),110755,fasting (between 14 and 18 hours),glucose (for 1.5 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000046,blood glucose level,,,,217.8,mg/dl,10.8,30.547,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (between 14 and 18 hours) then glucose (for 2 hours),110756,fasting (between 14 and 18 hours),glucose (for 2 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,10,,CMO:0000046,blood glucose level,,,,234,mg/dl,9.0,28.4605,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (between 14 and 18 hours) then glucose (for 2 hours),110757,fasting (between 14 and 18 hours),glucose (for 2 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,9,,CMO:0000046,blood glucose level,,,,219.6,mg/dl,7.2,21.6,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,fasting (between 14 and 18 hours) then glucose (for 2 hours),110758,fasting (between 14 and 18 hours),glucose (for 2 hours),, 3183,"Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22.",blood glucose amount,,RS:0001317,GK/MolTac,male,105 days,8,,CMO:0000046,blood glucose level,,,,120.6,mg/dl,3.6,10.1823,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,0,min,fasting (between 14 and 18 hours) then glucose,110744,fasting (between 14 and 18 hours),glucose,, 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,122.76,mg/dl,5.4,24.1495,MMO:0000113,oral glucose tolerance test,,0.0,,,,,resting (for 42 days) then fasting (for 12 hours),109901,resting (for 42 days),fasting (for 12 hours),, 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,165.06,mg/dl,3.78,16.9047,MMO:0000113,oral glucose tolerance test,,0.0,,,,,running (3.91 km/d) (for 42 days) then fasting (for 12 hours),109902,running (3.91 km/d) (for 42 days),fasting (for 12 hours),, 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,369.18,mg/dl,10.44,46.6891,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,resting (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 1 hours),109903,resting (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 1 hours), 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,295.02,mg/dl,14.58,65.2037,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,60,min,running (3.91 km/d) (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 1 hours),109904,running (3.91 km/d) (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 1 hours), 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,352.98,mg/dl,13.68,61.1788,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,resting (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours),109905,resting (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 2 hours), 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000046,blood glucose level,,,,262.44,mg/dl,15.84,70.8386,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,running (3.91 km/d) (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours),109906,running (3.91 km/d) (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 2 hours), 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000350,blood glucose level area under curve (AUC),,,,38075.27234652,(mg/dl) x min,978.5454,4376.1883,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,resting (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours),109907,resting (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 2 hours), 3160,"Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015.",blood glucose amount,,RS:0001299,GK,male,0 days,20,,CMO:0000350,blood glucose level area under curve (AUC),,,,29553.81788628,(mg/dl) x min,1274.7273,5700.7536,MMO:0000113,oral glucose tolerance test,,0.0,,oral glucose,120,min,running (3.91 km/d) (for 42 days) then fasting (for 12 hours) then glucose (1 g/kg) (for 2 hours),109908,running (3.91 km/d) (for 42 days),fasting (for 12 hours),glucose (1 g/kg) (for 2 hours), 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",blood glucose amount,,RS:0001840,Crlj:WI,male,56 days,5,,CMO:0000350,blood glucose level area under curve (AUC),,,,13284,(mg/dl) x min,1404.0,3139.4394,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 3 hours),110772,fasting (for 16 hours),glucose (2 g/kg) (for 3 hours),, 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",blood glucose amount,,RS:0004817,GK/CskCrlj,male,56 days,5,,CMO:0000350,blood glucose level area under curve (AUC),,,,22896,(mg/dl) x min,1404.0,3139.4394,MMO:0000113,oral glucose tolerance test,,0.0,,,,,fasting (for 16 hours) then glucose (2 g/kg) (for 3 hours),110773,fasting (for 16 hours),glucose (2 g/kg) (for 3 hours),,